SEC Form 3 · accession 0001104659-26-077822
Petros Pharmaceuticals, Inc. · PTPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Weinstein
Officer — Chief Accounting Officer
Period of report
Jun 18, 2026
Accepted (ET)
Jun 25, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001815903
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | holding | — | — | — | 636,004 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer, of which 3,004 shares are vested and the remainder of which will vest on February 2, 2027, (ii) 315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs, 2,500 of which will vest on July 2, 2026 and the remainder of which will vest on December 5, 2026.